溃疡性结肠炎临床诊疗规范要点评介.PDFVIP

现代消化及介入诊疗 2013 年 第18 卷第6 期 Modern Digestion Intervention 2013, Vol.18, No.6 -369- Overexpression Increases the Malignant Potential of Colorectal metastasis related factors in pancreatic cancer cells. Exp Ther Med, Cancer Cells: Roles of ERK1/2 and PI3K -Akt as Modulators of 2010,1(1):211-216. EGFR signaling. PLoS One, 2013,8(9):e74994. 29 Fujibe M, Chiba H, Kojima T, et al. Thr203 of claudin-1, a putative 23 Ip YC, Cheung ST, Lee YT, et al. Inhibition of hepatocellular carci－ phosphorylation site for MAP kinase, is required to promote the bar－ noma invasion by suppression of claudin -10 in HLE cells. Mol rier function of tight junctions. Exp Cell Res, 2004,295(1):36-47. Cancer Ther, 2007,6(11):2858-2867. 30 Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin 4 protein 24 Higashi Y, Suzuki S, Sakaguchi T, et al. Loss of claudin-1 expres－ expression in primary and metastatic pancreatic cancer: support for sion correlates with malignancy of hepatocellular carcinoma. J Surg use as a therapeutic target. Am J Clin Pathol, 2004,121(2):226-230. Res, 2007,139(1):68-76. 31 Michl P, Buchholz M, Rolke M, et al. Claudin4: a new target for 25 Lódi C, Szabó E, Holczbauer A, Batmunkh E, et al. Claudin4 differ－ pancreatic cancer treatment using clostridiurn perfringens entero－ entiates biliary tract cancers from hepatocellular carcinomas. Mod toxin. Gastroenterology, 2001,121(3):678-684. Pathol, 2006,19(3):460-469. 32 Saeki R, Kondoh M, Kakutani H, et al. A claudin -targeting 26 Borka K, Kaliszky P, Szabó E, et al. Claudin expression in pancreat－ molecule as an inhibitor of tumor metastasis. J Pharmacol Exp Ther, ic endocrine tumors as compared with ductal adenocarcinomas. 2010,334(2):576-582. Virchows Arch, 2007,450(5):549-557. 33 W觟ll S, Schlitter AM, Dhaene K